Search results
Study finds the rate of withdrawal from quitting antidepressants
CNN via Yahoo News· 11 hours agoThe occurrence of withdrawal symptoms was reported or described as early as 1959, but researchers...
Study: Treatment-Resistant Depression Linked to BMI
SciTechDaily· 6 hours agoRecent research highlights a genetic contribution to treatment-resistant depression, linking it with several health disorders and suggesting new...
J&J’s seltorexant meets all endpoints in Phase III MDD trial
Clinical Trials Arena via Yahoo Finance· 7 days agoJohnson & Johnson (J&J) has announced that its seltorexant medication met all the primary and...
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression - BrainsWay (NASDAQ:BWAY)
Benzinga· 3 days agoAdministration (FDA) has granted an expanded indication for the Company's Deep Transcranial Magnetic Stimulation system (Deep TMS™) allowing for the treatment of patients with major ...
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study...
Psychedelic Therapy Sees Challenges Despite Promising Results
WebMD· 15 hours agoWhen Victoria Tennant, 31, woke up the day after her first psychedelic treatment, she felt like someone had taken her “brain out, put it in a bowl of ice, and then put it back” in her head.
Shared genetic links between sleep and neuropsychiatric conditions may lead to new treatments
Medical Xpress· 2 days ago...While it is understandable that the symptoms of such conditions would lead to sleep disruption...
New Study Reveals Key Brain Differences in Depression
Tehachapi News· 3 days agoThis extensive study, published in Translational Psychiatry, is one of the largest of its kind and involved 338 patients diagnosed with major depressive ...
FDA expands age range for BrainsWay Deep TMS treatment By Investing.com
Investing.com· 3 days agoAdministration (FDA) has approved an expanded age indication for its Deep Transcranial Magnetic...
Guest column: With FDA approval of software treatment for depression, the digital medicine...
WRAL TechWire· 6 days agoIn a watershed moment for digital health innovation, the FDA recently granted clearance to Rejoyn, a...